Repeated clear benefits of immunotherapy in a patient with Charcot-Marie-Tooth disease carrying a rare point mutation in PMP22

被引：0

作者：

Kawai, Honami ^{[1
]}

Nishida, Yoichiro ^{[1
]}

Kanda, Takashi ^{[2
]}

Yokota, Takanori ^{[1
]}

机构：

[1] Inst Sci Tokyo, Grad Sch Med & Dent Sci, Dept Neurol & Neurol Sci, 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138519, Japan

[2] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Yamaguchi 7558505, Japan

来源：

NEUROGENETICS | 2025年 / 26卷 / 01期

关键词：

Charcot-Marie-Tooth disease (CMT); PMP22; Point mutation; Chronic inflammatory demyelinating polyneuropathy (CIDP); Optic neuritis;

D O I：

10.1007/s10048-025-00808-9

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

We describe a unique patient who had been diagnosed with inflammatory demyelinating polyneuropathy (CIDP) for 13 years with frequent clear responses to immunotherapies and was finally diagnosed with Charcot-Marie-Tooth disease (CMT) with a rare point mutation in PMP22 (c.320G > A, p.G107D). Some patients diagnosed with young-onset CIDP may have underlying CMT, and extensive genetic testing including point mutations of PMP22 gene is required not to miss the diagnosis.

引用

页数：4

共 50 条

[21] Histopathologic findings of three Charcot-Marie-Tooth patients with PMP22 mutation and Dejerine-Sottas Syndrome
Koo, H. -S.
Kim, S. -H.
Choi, B. -O.
Park, J. -Y.
VIRCHOWS ARCHIV, 2012, 461 : S85 - S86
[22] SNP analysis of PMP22 and predicted PMP22 targeting mir genes in Charcot-Marie-Tooth neuropathy type 1A
Nam, S. H.
Lee, H. J.
Shin, B. L.
Choi, B. O.
Chung, K. W.
MOLECULAR BIOLOGY OF THE CELL, 2013, 24
[23] Copy number variation upstream of PMP22 in Charcot–Marie–Tooth disease
Marian AJ Weterman
Fred van Ruissen
Marit de Wissel
Lou Bordewijk
Johnny PA Samijn
W Ludo van der Pol
Farid Meggouh
Frank Baas
European Journal of Human Genetics, 2010, 18 : 421 - 428
[24] Intermediate form of Charcot-Marie-Tooth with a new single nucleotide deletion of PMP22 gene
Luigetti, M.
Sabatelli, M.
Zollino, M.
Conte, A.
Madia, F.
Mereu, M. L.
Marangi, G.
Pomponi, M. G.
Tonali, P. A.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2007, 12 (02) : 161 - 162
[25] New mutation in a patient with Charcot-Marie-Tooth disease
Dominguez Diez, F. J.
Lopez Alburquerque, J. T.
NEUROLOGIA, 2019, 34 (08): : 546 - 547
[26] Clinical and Genetic Diversity of PMP22 Mutations in a Large Cohort of Chinese Patients With Charcot-Marie-Tooth Disease
Liu, Xiaoxuan
Duan, Xiaohui
Zhang, Yingshuang
Fan, Dongsheng
FRONTIERS IN NEUROLOGY, 2020, 11
[27] Compound heterozygous PMP22 deletion mutations causing severe Charcot-Marie-Tooth disease type 1
Abe, Akiko
Nakamura, Kazuyuki
Kato, Mitsuhiro
Numakura, Chikahiko
Honma, Tomomi
Seiwa, Chizuru
Shirahata, Emi
Itoh, Aiko
Kishikawa, Yumiko
Hayasaka, Kiyoshi
JOURNAL OF HUMAN GENETICS, 2010, 55 (11) : 771 - 773
[28] Treating PMP22 gene duplication-related Charcot-Marie-Tooth disease: the past, the present and the future
Boutary, Suzan
Echaniz-Laguna, Andoni
Adams, David
Loisel-Duwattez, Julien
Schumacher, Michael
Massaad, Charbel
Massaad-Massade, Liliane
TRANSLATIONAL RESEARCH, 2021, 227 : 100 - 111
[29] Squalenoyl siRNA PMP22 nanoparticles, a potent therapy for Charcot-Marie-Tooth disease type 1A
Boutary, Suzan
Massaad-Massade, Liliane
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2021, 26 (03) : 363 - 364
[30] Mutational analysis of PMP22 and CJB1 genes in Greek patients with Charcot-Marie-Tooth disease
Floroskufi, P.
Panas, M.
Karadima, G.
Vassilopoulos, D.
EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 279 - 280

← 1 2 3 4 5 →